This compound is primarily used in pharmaceutical research and development as a key intermediate in the synthesis of various bioactive molecules. Its structure, featuring both amino and hydroxymethyl groups, makes it valuable for constructing complex drug candidates, particularly in the field of protease inhibitors and other therapeutic agents targeting neurological and infectious diseases. The tert-butyloxycarbonyl (Boc) protecting group enhances its stability during chemical reactions, allowing for selective modifications in multi-step synthetic processes. Additionally, its stereochemistry is crucial for achieving the desired biological activity in chiral drug molecules.